National Health (Price and Special Patient Contribution) Amendment Determination 2020 (No. 4) (PB 50 of 2020) (Cth)

Case

PB 50 of 2020

National Health (Price and Special Patient Contribution) Amendment Determination 2020 (No. 4)

National Health Act 1953

___________________________________________________________________________

I, THEA DANIEL, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Determination under section 85B of the National Health Act 1953.

Dated    29 May 2020

THEA DANIEL

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

_________________________________________________________________________

  1. Name of Instrument

(1)This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2020 (No. 4).

(2)This Instrument may also be cited as PB 50 of 2020.

  1. Commencement

This Instrument commences on 1 June 2020.

  1. Amendment of National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)

Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).

Schedule 1     Amendments

  1. Schedule 1, entry for Diltiazem

Omit:

Diltiazem Capsule (controlled delivery) containing diltiazem hydrochloride 180 mg Oral Cardizem CD 30 6.25 8.02
Capsule (controlled delivery) containing diltiazem hydrochloride 240 mg Oral Cardizem CD 30 8.45 10.22
Capsule (controlled delivery) containing diltiazem hydrochloride 360 mg Oral Cardizem CD 30 11.08 12.84
Tablet containing diltiazem hydrochloride 60 mg Oral Cardizem 90 5.64 7.40
Vasocardol 90 5.64 7.40

Substitute:

Diltiazem Capsule (controlled delivery) containing diltiazem hydrochloride 180 mg Oral Cardizem CD 30 6.25 8.02
Capsule (controlled delivery) containing diltiazem hydrochloride 240 mg Oral Cardizem CD 30 8.45 10.22
Capsule (controlled delivery) containing diltiazem hydrochloride 360 mg Oral Cardizem CD 30 11.08 12.84
Tablet containing diltiazem hydrochloride 60 mg Oral Cardizem 90 5.64 7.40
  1. Schedule 1, omit entry for Doxepin

  1. Schedule 1, entry for Quinapril

Omit:

Quinapril Tablet 5 mg (as hydrochloride) Oral Accupril 30 2.91 6.82
Tablet 10 mg (as hydrochloride) Oral Accupril 30 3.71 7.62
Tablet 20 mg (as hydrochloride) Oral Accupril 30 4.58 8.48

Substitute:

Quinapril Tablet 5 mg (as hydrochloride) Oral Accupril 30 2.91 6.82
Tablet 10 mg (as hydrochloride) Oral Accupril 30 3.71 7.62
Actions
Download as PDF Download as Word Document


Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0